FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013065324> ?p ?o ?g. }

• W2013065324 endingPage "721" @default.
• W2013065324 startingPage "714" @default.
• W2013065324 abstract "First-line treatment for patients with superficial femoral arterial (SFA) occlusive disease has yet to be determined. This study compared long-term outcomes between primary SFA stent placement and primary femoral-popliteal bypass. Periprocedural patient factors were examined to determine their effect on these results.All femoral-popliteal bypasses and SFA interventions performed in consecutive patients with symptoms Rutherford 3 to 6 between 2001 and 2008 were reviewed. Time-dependent outcomes were analyzed using the Kaplan-Meier method and log-rank test. Cox proportional hazards were performed to determine predictors of graft patency. Multivariate analysis was completed to identify patient covariates most often associated with the primary therapy.A total of 152 limbs in 141 patients (66% male; mean age, 66 ± 22 years) underwent femoral-popliteal bypass, and 233 limbs in 204 patients (49% male; mean age, 70 ± 11 years) underwent SFA interventions. Four-year primary, primary-assisted, and secondary patency rates were 69%, 78%, and 83%, respectively, for bypass patients and 66%, 91%, and 95%, respectively, for SFA interventions. Six-year limb salvage was 80% for bypass vs 92% for stenting (P = .04). Critical limb ischemia (CLI) and renal insufficiency were predictors of bypass failure. Claudication was a predictor of success for SFA stenting. Three-year limb salvage rates for CLI patients undergoing surgery and SFA stenting were 83%. Amputation-free survival at 3 years for CLI patients was 55% for bypass and 59% for SFA interventions. Multivariate predictors (odds ratios and 95% confidence intervals) of covariates most frequently associated with first-line SFA stenting were TransAtlantic Inter-Society Consensus II A and B lesions (5.9 [3.4-9.1], P < .001), age >70 years (2.1 [1.4-3.1], P < .001), and claudication (1.7 [1.1-2.7], P = .01). Regarding bypass as first-line therapy, claudicant patients were more likely to have nondiabetic status (5.6 [3.3-9.4], P < .001), creatinine <1.8 mg/dL (4.6 [1.5-14.9], P = .01), age <70 years (2.7 [CI, 1.6-8.3], P < .001), and presence of an above-knee popliteal artery target vessel (1.9 [CI, 1.1-3.4] P = .02).Indication, patient-specific covariates, and anatomic lesion classification have significant association when determining surgeon selection of SFA stenting or femoral-popliteal bypass as first-line therapy. Patients with SFA disease can have comparable long-term results when treatment options are well matched to patient-specific and anatomic characteristics." @default.
• W2013065324 created "2016-06-24" @default.
• W2013065324 creator A5009887110 @default.
• W2013065324 creator A5030045473 @default.
• W2013065324 creator A5030870079 @default.
• W2013065324 creator A5041234012 @default.
• W2013065324 creator A5045547193 @default.
• W2013065324 creator A5045922184 @default.
• W2013065324 creator A5053614501 @default.
• W2013065324 creator A5065001569 @default.
• W2013065324 date "2011-09-01" @default.
• W2013065324 modified "2023-10-06" @default.
• W2013065324 title "Long-term results of open and endovascular revascularization of superficial femoral artery occlusive disease" @default.
• W2013065324 cites W1971064841 @default.
• W2013065324 cites W1975866353 @default.
• W2013065324 cites W1981400524 @default.
• W2013065324 cites W1993182405 @default.
• W2013065324 cites W2009254740 @default.
• W2013065324 cites W2015230402 @default.
• W2013065324 cites W2018852205 @default.
• W2013065324 cites W2027163052 @default.
• W2013065324 cites W2036296835 @default.
• W2013065324 cites W2040208068 @default.
• W2013065324 cites W2049813945 @default.
• W2013065324 cites W2069424077 @default.
• W2013065324 cites W2071979777 @default.
• W2013065324 cites W2143997944 @default.
• W2013065324 cites W2144985796 @default.
• W2013065324 cites W2145994607 @default.
• W2013065324 cites W2149859437 @default.
• W2013065324 cites W2151990412 @default.
• W2013065324 cites W2158595322 @default.
• W2013065324 cites W2569906950 @default.
• W2013065324 doi "https://doi.org/10.1016/j.jvs.2011.03.216" @default.
• W2013065324 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5292274" @default.
• W2013065324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21620611" @default.
• W2013065324 hasPublicationYear "2011" @default.
• W2013065324 type Work @default.
• W2013065324 sameAs 2013065324 @default.
• W2013065324 citedByCount "44" @default.
• W2013065324 countsByYear W20130653242012 @default.
• W2013065324 countsByYear W20130653242013 @default.
• W2013065324 countsByYear W20130653242014 @default.
• W2013065324 countsByYear W20130653242015 @default.
• W2013065324 countsByYear W20130653242016 @default.
• W2013065324 countsByYear W20130653242017 @default.
• W2013065324 countsByYear W20130653242018 @default.
• W2013065324 countsByYear W20130653242019 @default.
• W2013065324 countsByYear W20130653242020 @default.
• W2013065324 countsByYear W20130653242021 @default.
• W2013065324 countsByYear W20130653242022 @default.
• W2013065324 countsByYear W20130653242023 @default.
• W2013065324 crossrefType "journal-article" @default.
• W2013065324 hasAuthorship W2013065324A5009887110 @default.
• W2013065324 hasAuthorship W2013065324A5030045473 @default.
• W2013065324 hasAuthorship W2013065324A5030870079 @default.
• W2013065324 hasAuthorship W2013065324A5041234012 @default.
• W2013065324 hasAuthorship W2013065324A5045547193 @default.
• W2013065324 hasAuthorship W2013065324A5045922184 @default.
• W2013065324 hasAuthorship W2013065324A5053614501 @default.
• W2013065324 hasAuthorship W2013065324A5065001569 @default.
• W2013065324 hasBestOaLocation W20130653241 @default.
• W2013065324 hasConcept C126322002 @default.
• W2013065324 hasConcept C141071460 @default.
• W2013065324 hasConcept C156957248 @default.
• W2013065324 hasConcept C2776204877 @default.
• W2013065324 hasConcept C2777303625 @default.
• W2013065324 hasConcept C2777466421 @default.
• W2013065324 hasConcept C2778963770 @default.
• W2013065324 hasConcept C2779464278 @default.
• W2013065324 hasConcept C2781099653 @default.
• W2013065324 hasConcept C3018348675 @default.
• W2013065324 hasConcept C44249647 @default.
• W2013065324 hasConcept C500558357 @default.
• W2013065324 hasConcept C50382708 @default.
• W2013065324 hasConcept C71924100 @default.
• W2013065324 hasConceptScore W2013065324C126322002 @default.
• W2013065324 hasConceptScore W2013065324C141071460 @default.
• W2013065324 hasConceptScore W2013065324C156957248 @default.
• W2013065324 hasConceptScore W2013065324C2776204877 @default.
• W2013065324 hasConceptScore W2013065324C2777303625 @default.
• W2013065324 hasConceptScore W2013065324C2777466421 @default.
• W2013065324 hasConceptScore W2013065324C2778963770 @default.
• W2013065324 hasConceptScore W2013065324C2779464278 @default.
• W2013065324 hasConceptScore W2013065324C2781099653 @default.
• W2013065324 hasConceptScore W2013065324C3018348675 @default.
• W2013065324 hasConceptScore W2013065324C44249647 @default.
• W2013065324 hasConceptScore W2013065324C500558357 @default.
• W2013065324 hasConceptScore W2013065324C50382708 @default.
• W2013065324 hasConceptScore W2013065324C71924100 @default.
• W2013065324 hasIssue "3" @default.
• W2013065324 hasLocation W20130653241 @default.
• W2013065324 hasLocation W20130653242 @default.
• W2013065324 hasLocation W20130653243 @default.
• W2013065324 hasLocation W20130653244 @default.
• W2013065324 hasOpenAccess W2013065324 @default.
• W2013065324 hasPrimaryLocation W20130653241 @default.
• W2013065324 hasRelatedWork W1997445984 @default.

• next